View in EDS HTML Full Text PDF Full Text

Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma.

Saved in:
Bibliographic Details
Title: Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma.
Authors: Stewart AK; Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA. Stewart.Keith@mayo.edu., Krishnan AY; Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Medical Center, Duarte, CA, USA., Singhal S; Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Boccia RV; Center for Cancer and Blood Disorders, Bethesda, MD, USA., Patel MR; Florida Cancer Specialists, Sarasota, FL, USA.; Sarah Cannon Research Institute, Nashville, TN, USA., Niesvizky R; Multiple Myeloma Center, New York Presbyterian Hospital-Cornell Medical Center, New York, NY, USA., Chanan-Khan AA; Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL, USA., Ailawadhi S; Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL, USA., Brumm J; Genentech, Inc., South San Francisco, CA, USA., Mundt KE; Genentech, Inc., South San Francisco, CA, USA., Hong K; Genentech, Inc., South San Francisco, CA, USA., McBride J; Genentech, Inc., South San Francisco, CA, USA., Shon-Nguyen Q; Genentech, Inc., South San Francisco, CA, USA., Xiao Y; Genentech, Inc., South San Francisco, CA, USA., Ramakrishnan V; Genentech, Inc., South San Francisco, CA, USA., Polson AG; Genentech, Inc., South San Francisco, CA, USA., Samineni D; Genentech, Inc., South San Francisco, CA, USA., Leipold D; Genentech, Inc., South San Francisco, CA, USA., Humke EW; Genentech, Inc., South San Francisco, CA, USA., McClellan JS; Genentech, Inc., South San Francisco, CA, USA., Berdeja JG; Sarah Cannon Research Institute, Nashville, TN, USA.
Source: Blood cancer journal [Blood Cancer J] 2019 Feb 04; Vol. 9 (2), pp. 17. Date of Electronic Publication: 2019 Feb 04.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30718503
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stewart+AK%22">Stewart AK</searchLink>; Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ, USA. Stewart.Keith@mayo.edu.<br /><searchLink fieldCode="AU" term="%22Krishnan+AY%22">Krishnan AY</searchLink>; Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Medical Center, Duarte, CA, USA.<br /><searchLink fieldCode="AU" term="%22Singhal+S%22">Singhal S</searchLink>; Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Boccia+RV%22">Boccia RV</searchLink>; Center for Cancer and Blood Disorders, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Patel+MR%22">Patel MR</searchLink>; Florida Cancer Specialists, Sarasota, FL, USA.; Sarah Cannon Research Institute, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Niesvizky+R%22">Niesvizky R</searchLink>; Multiple Myeloma Center, New York Presbyterian Hospital-Cornell Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Chanan-Khan+AA%22">Chanan-Khan AA</searchLink>; Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Ailawadhi+S%22">Ailawadhi S</searchLink>; Division of Hematology & Oncology, Mayo Clinic, Jacksonville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Brumm+J%22">Brumm J</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mundt+KE%22">Mundt KE</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hong+K%22">Hong K</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22McBride+J%22">McBride J</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Shon-Nguyen+Q%22">Shon-Nguyen Q</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Xiao+Y%22">Xiao Y</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ramakrishnan+V%22">Ramakrishnan V</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Polson+AG%22">Polson AG</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Samineni+D%22">Samineni D</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Leipold+D%22">Leipold D</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Humke+EW%22">Humke EW</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22McClellan+JS%22">McClellan JS</searchLink>; Genentech, Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Berdeja+JG%22">Berdeja JG</searchLink>; Sarah Cannon Research Institute, Nashville, TN, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2019 Feb 04; Vol. 9 (2), pp. 17. <i>Date of Electronic Publication: </i>2019 Feb 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30718503
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-019-0178-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17
    Titles:
      – TitleFull: Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stewart AK
      – PersonEntity:
          Name:
            NameFull: Krishnan AY
      – PersonEntity:
          Name:
            NameFull: Singhal S
      – PersonEntity:
          Name:
            NameFull: Boccia RV
      – PersonEntity:
          Name:
            NameFull: Patel MR
      – PersonEntity:
          Name:
            NameFull: Niesvizky R
      – PersonEntity:
          Name:
            NameFull: Chanan-Khan AA
      – PersonEntity:
          Name:
            NameFull: Ailawadhi S
      – PersonEntity:
          Name:
            NameFull: Brumm J
      – PersonEntity:
          Name:
            NameFull: Mundt KE
      – PersonEntity:
          Name:
            NameFull: Hong K
      – PersonEntity:
          Name:
            NameFull: McBride J
      – PersonEntity:
          Name:
            NameFull: Shon-Nguyen Q
      – PersonEntity:
          Name:
            NameFull: Xiao Y
      – PersonEntity:
          Name:
            NameFull: Ramakrishnan V
      – PersonEntity:
          Name:
            NameFull: Polson AG
      – PersonEntity:
          Name:
            NameFull: Samineni D
      – PersonEntity:
          Name:
            NameFull: Leipold D
      – PersonEntity:
          Name:
            NameFull: Humke EW
      – PersonEntity:
          Name:
            NameFull: McClellan JS
      – PersonEntity:
          Name:
            NameFull: Berdeja JG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 02
              Text: 2019 Feb 04
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1